Corey L - Search Results

1

Analysis of the HIV Vaccine Trials Network 702 Phase 2b-3 HIV-1 Vaccine Trial in South Africa Assessing RV144 Antibody and T-Cell Correlates of HIV-1 Acquisition Risk.

Moodie Z, Dintwe O, Sawant S, Grove D, Huang Y, Janes H, Heptinstall J, Omar FL, Cohen K, De Rosa SC, Zhang L, Yates NL, Sarzotti-Kelsoe M, Seaton KE, Laher F, Bekker LG, Malahleha M, Innes C, Kassim S, Naicker N, Govender V, Sebe M, Singh N, Kotze P, Lazarus E, Nchabeleng M, Ward AM, Brumskine W, Dubula T, Randhawa AK, Grunenberg N, Hural J, Kee JJ, Benkeser D, Jin Y, Carpp LN, Allen M, D'Souza P, Tartaglia J, DiazGranados CA, Koutsoukos M, Gilbert PB, Kublin JG, Corey L, Andersen-Nissen E, Gray GE, Tomaras GD, McElrath MJ. Moodie Z, et al. Among authors: corey l. J Infect Dis. 2022 Aug 24;226(2):246-257. doi: 10.1093/infdis/jiac260. J Infect Dis. 2022. PMID: 35758878 Free PMC article. Clinical Trial.

2

Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers.

Ferrari G, Humphrey W, McElrath MJ, Excler JL, Duliege AM, Clements ML, Corey LC, Bolognesi DP, Weinhold KJ. Ferrari G, et al. Among authors: corey lc. Proc Natl Acad Sci U S A. 1997 Feb 18;94(4):1396-401. doi: 10.1073/pnas.94.4.1396. Proc Natl Acad Sci U S A. 1997. PMID: 9037064 Free PMC article.

3

Early induction and maintenance of Env-specific T-helper cells following human immunodeficiency virus type 1 infection.

Malhotra U, Holte S, Zhu T, Delpit E, Huntsberry C, Sette A, Shankarappa R, Maenza J, Corey L, McElrath MJ. Malhotra U, et al. Among authors: corey l. J Virol. 2003 Feb;77(4):2663-74. doi: 10.1128/jvi.77.4.2663-2674.2003. J Virol. 2003. PMID: 12552005 Free PMC article.

4

Persistence of extraordinarily low levels of genetically homogeneous human immunodeficiency virus type 1 in exposed seronegative individuals.

Zhu T, Corey L, Hwangbo Y, Lee JM, Learn GH, Mullins JI, McElrath MJ. Zhu T, et al. Among authors: corey l. J Virol. 2003 Jun;77(11):6108-16. doi: 10.1128/jvi.77.11.6108-6116.2003. J Virol. 2003. PMID: 12743268 Free PMC article.

5

Comprehensive analysis of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-secreting CD8+ T cells in primary HIV-1 infection.

Cao J, McNevin J, Holte S, Fink L, Corey L, McElrath MJ. Cao J, et al. Among authors: corey l. J Virol. 2003 Jun;77(12):6867-78. doi: 10.1128/jvi.77.12.6867-6878.2003. J Virol. 2003. PMID: 12768006 Free PMC article.

6

What constitutes efficacy for a human immunodeficiency virus vaccine that ameliorates viremia: issues involving surrogate end points in phase 3 trials.

Gilbert PB, DeGruttola VG, Hudgens MG, Self SG, Hammer SM, Corey L. Gilbert PB, et al. Among authors: corey l. J Infect Dis. 2003 Jul 15;188(2):179-93. doi: 10.1086/376449. Epub 2003 Jul 1. J Infect Dis. 2003. PMID: 12854072

7

Reduced levels of neutralizing antibodies to Kaposi sarcoma-associated herpesvirus in persons with a history of Kaposi sarcoma.

Kimball LE, Casper C, Koelle DM, Morrow R, Corey L, Vieira J. Kimball LE, et al. Among authors: corey l. J Infect Dis. 2004 Jun 1;189(11):2016-22. doi: 10.1086/386371. Epub 2004 May 11. J Infect Dis. 2004. PMID: 15143468

8

Frequent reactivation of herpes simplex virus among HIV-1-infected patients treated with highly active antiretroviral therapy.

Posavad CM, Wald A, Kuntz S, Huang ML, Selke S, Krantz E, Corey L. Posavad CM, et al. Among authors: corey l. J Infect Dis. 2004 Aug 15;190(4):693-6. doi: 10.1086/422755. Epub 2004 Jul 13. J Infect Dis. 2004. PMID: 15272395

9

Analysis of genetic polymorphisms in CCR5, CCR2, stromal cell-derived factor-1, RANTES, and dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin in seronegative individuals repeatedly exposed to HIV-1.

Liu H, Hwangbo Y, Holte S, Lee J, Wang C, Kaupp N, Zhu H, Celum C, Corey L, McElrath MJ, Zhu T. Liu H, et al. Among authors: corey l. J Infect Dis. 2004 Sep 15;190(6):1055-8. doi: 10.1086/423209. Epub 2004 Aug 2. J Infect Dis. 2004. PMID: 15319853

10

Polyamides reveal a role for repression in latency within resting T cells of HIV-infected donors.

Ylisastigui L, Coull JJ, Rucker VC, Melander C, Bosch RJ, Brodie SJ, Corey L, Sodora DL, Dervan PB, Margolis DM. Ylisastigui L, et al. Among authors: corey l. J Infect Dis. 2004 Oct 15;190(8):1429-37. doi: 10.1086/423822. Epub 2004 Sep 15. J Infect Dis. 2004. PMID: 15378435

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,091 results

Search Page

Filters